miR-206 has exhibited its regulation of fibroblast growth factor, Hmgb3 and HIF-1α/Fhl-1 pathways in amyotrophic lateral sclerosis, muscle regeneration and pulmonary hypertension, respectively [31–33]. This evidence concerns the gene HMGB3 and amyotrophic lateral sclerosis.